ArticleJournal of translational medicine2026
Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide.
Xueqian Shuai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.